Observational studyBMC anesthesiology2026
Effect of norepinephrine initiation timing on mortality in septic shock: a multicenter cohort study.
Observational study in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundThis study aims to investigate the association between timing of norepinephrine (NE) initiation and mortality in septic shock.
methodsWe conducted a retrospective study using data from a multicenter database. Adult patients with septic shock presenting to the emergency departments, who showed initial hypotension and received NE, were included. We performed multivariable regression analysis to evaluate the association between norepinephrine timing and 28-day mortality, with stratifying according to the Sepsis-3 shock definition and vasopressor requirement risk assessed by the diastolic shock index and lactate levels.
resultsA total of 4,456 patients were included. In the non-Sepsis-3 shock group, no significant association was found between the timing of NE administration and 28-day mortality. However, in the Sepsis-3 shock group, a significant association was observed, with each hourly delay in NE administration increasing the risk of 28-day mortality (aOR for hourly delay: 1.07, 95% CI: 1.02–1.13, P = 0.002). Compared to the > 6-hour group, the aOR for 28-day high vasopressor requirement risk. mortality was 0.54 (95% CI: 0.35–0.81, P = 0.003) for norepinephrine administration within 1 h and 0.63 (95% CI: 0.42–0.95, P = 0.025) for the 1–3 h group. In the high-vasopressor requirement risk, hourly delay in NE administration was also associated with an increased risk of 28-day mortality (aOR for hourly delay: 1.07, 95% CI: 1.00-1.13, P = 0.027). Compared to the > 6-hour group, the aOR for 28-day mortality was 0.53 (95% CI: 0.33–0.86, P = 0.010) for within 1 h group.
conclusionsEarly NE administration was associated with decreased 28-day mortality in patients who met the Sepsis-3 septic shock criteria and who had high vasopressor requirement risk.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.